Sleep apnea is a life-threatening and
serious sleep disorder that generally occurs when an individual’s
breathing is disturbed during sleep. In individuals with sleep apnea,
the tissue located behind the throat and between the mouth and the lungs
briefly collapses and at times, it becomes so constricted that the
breathing stops either momentarily or for longer durations and
sometimes, for several minutes. During such events, the body sensors
send a signal to the brain, which awakens the individual from sleep,
leading to re-opening of the airways. People suffering from sleep apnea
are unable to enjoy the deep level of recovery-style and restful sleep
that is normally required by the body to function at an optimal
capacity.
Sleep apnea has been classified into three categories viz.
obstructive sleep apnea (OSA), mixed sleep apnea, and central sleep
apnea (CSA). Obstructive sleep apnea (OSA) is the most prevalent type,
accounting for 84% of all diagnosed cases of sleep apnea. In OSA,
obstruction in the upper airway (the nose or the throat) stops the flow
of air to the lungs. In central sleep apnea (CSA), the nasal airway is
open, but the brain is unable to send signals to the muscles to breathe,
due to which respiration does not occur. Mixed sleep apnea is a mixture
of both CSA and OSA. Symptoms associated with sleep apnea include loud
snoring, morning headaches, restless sleep, insomnia, and recurrent
awakenings. Sleep apnea can also lead to several health issues such as
high blood pressure, heart failure, stroke, irregular heartbeats, heart
attacks, diabetes, and depression. The condition can be treated with the
help of the continuous positive airway pressure (CPAP) treatment or
sleep apnea dental devices. An individual can also be advised to undergo
surgeries such as uvulopalatopharyngoplasty (UPPP) and mandibular
maxillar advancement surgery.
The rising number of patients with sleep apnea across the globe is
driving the sleep apnea market. According to a study conducted by the
World Health Organization (WHO), the global prevalence of sleep apnea is
around 100 million people. In the U.S. alone, the number of people with
sleep-disordered breathing (SDB) is around 42 million. One out of five
adults in the U.S. have mild OSA, while one out of 15 have moderate to
severe OSA. The number is expected to increase in the next few years,
primarily due to increasing incidence of sleep-related disorders. This
is projected to drive the sleep apnea market from 2017 to 2025. The
other factors anticipated to augment the market are increasing awareness
about adverse effects of sleep apnea, growing use of oral appliances
for the treatment of sleep apnea, and technological advancements
resulting in the development of novel products for treating sleep apnea.
On the contrary, alternative treatment options and patient compliance
issues can negatively impact the market in the near future. Increasing
number of companies entering the sleep apnea market and growth
opportunities in emerging markets are factors projected to offer
lucrative growth opportunities to manufacturers of sleep apnea treatment
devices during the forecast period.
The global sleep apnea market has been
segmented based on product, end-user, and region. In terms of product,
the market has been classified into positive airway pressure (PAP)
devices, oral appliances, pillows, nasal straps, and other accessories.
In terms of end-user, the market has been segmented into hospitals,
clinics, and home care settings.
In terms of geography, the global sleep apnea market has been divided
into North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa. North America accounts for a leading share of the
global sleep apnea market, due to increasing prevalence of sleep apnea
in the region and rising investments by manufacturers for the
development of novel products with enhanced features for sleep apnea
treatment. The market in Asia Pacific is anticipated to register the
maximum growth rate during the forecast period, due to growing awareness
among patients in the region about ill-effects of untreated sleep
apnea.
Key players operating in the global sleep
apnea market are Resmed, Inc., Fisher & Paykel Healthcare Ltd.,
Somnomed Limited, Philips Healthcare, Whole You, Inc., MEDiTAS Ltd,
Sleeping Well, LLC, and Tomed GmbH.
No comments:
Post a Comment